000 02268nam a22003855i 4500
001 81392
003 ES-MaUEC
005 20230207040327.0
007 cr nn 008mamaa
008 150514s2015 gw | s |||| 0|eng d
020 _a9783319165226
024 7 _a10.1007/978-3-319-16522-6
_2doi
050 4 _aRM334
_b.C646 2015
245 1 0 _aCognitive Enhancement
_cedited by Kathleen M. Kantak, Joseph G. Wettstein.
260 _aCham, Switzerland
_bSpringer
_c2015
300 _a1 recurso en línea (VIII, 470 páginas)
_b30 ilustraciones, 24 ilustraciones en color
336 _aTexto
_btxt
_2rdacontent
337 _aelectrónico
_bc
_2rdamedia
338 _arecurso electrónico
_bcr
_2rdacarrier
490 0 _aHandbook of Experimental Pharmacology
_x0171-2004
_v228
505 0 _aPreface -- PartÂ{u1BA0}Basic Approaches andÂ{u0972}spectives -- PartÂ{u2BA0}Cognitive Domains for Pharmacological Intervention: Implications for Neuropsychiatric and Neurological Illnesses -- Part 3. Developmental Disorders, Emerging Technologies and Ethical Considerations.
520 3 _aThis book highlights the behavioral and neurobiological issues relevant for drug development, reviews evidence for an innovative approach for drug discovery and presents perspectives on multiple special topics ranging from therapeutic drug use in children, emerging technologies and non-pharmacological approaches to cognitive enhancement.
710 2 _aSpringerLink (Online service)
_0Local
_9106996
942 _2lcc
_cLE
988 _aEBOOK, EBSPRINGER, asignarmaterias_11febrero
650 0 _9139882
_aPsicofarmacología
_0
650 7 _aNeurociencias
_0
_2embne
_9158907
650 7 _aFarmacología
_0
_2embne
_9137893
700 1 _aKantak, Kathleen M.
_eeditor literario
_0Local
_993785
700 1 _aWettstein, Joseph G
_eeditor literario
_993786
_0Local
856 4 0 _uhttps://go.openathens.net/redirector/universidadeuropea.es?url=https://link.springer.com/book/10.1007/978-3-319-16522-6
_zAcceso a este recurso digital (usuarios Universidad Europea de Madrid)
907 _a.b12899823
_b10-10-17
_c18-01-16
998 _am
_a_alco
_a_vill
_b - -
_cm
_dz
_e-
_feng
_ggw
_h0
945 _aRM334 .C646 2015 EB
_g1
_ieBOOK
_j0
_lmae
_o-
_pEUR0.00
_q-
_r-
_sb
_t15
_u0
_v0
_w0
_x0
_y.i1156944x
_z06-04-17
999 _c81392
_d81392
_x1